{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T23:49:55Z","timestamp":1783640995407,"version":"3.55.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.crad.2010.03.012","type":"journal-article","created":{"date-parts":[[2010,6,11]],"date-time":"2010-06-11T04:57:49Z","timestamp":1276232269000},"page":"536-548","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Non FDG PET"],"prefix":"10.1016","volume":"65","author":[{"given":"C.","family":"Nanni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Fantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Nicolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Fanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.crad.2010.03.012_bib1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.pneumo.2009.08.008","article-title":"Comparison between PET(-FDG) and computed tomography in the staging of lung cancer. Consequences for operability in 94 patients","volume":"65","author":"Pr\u00e9vost","year":"2009","journal-title":"Rev Pneumol Clin"},{"issue":"4","key":"10.1016\/j.crad.2010.03.012_bib2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ejso.2009.11.009","article-title":"The role of FDG PET\/CT in patients with locoregional breast cancer recurrence: a comparison to conventional imaging techniques","volume":"36","author":"Aukema","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.crad.2010.03.012_bib3","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.3109\/10428190903308056","article-title":"Interim 18F-fluorodeoxyglucose positron emission tomography in diffuse large B-cell lymphoma: qualitative or quantitative interpretation\u2014where do we stand?","volume":"50","author":"Meignan","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.crad.2010.03.012_bib4","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1200\/JCO.2008.19.7814","article-title":"Early and late therapy response assessment with [18F]fluorodeoxyglucose positron emission tomography in pediatric Hodgkin\u2019s lymphoma: analysis of a prospective multicenter trial","volume":"27","author":"Furth","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.crad.2010.03.012_bib5","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00277-009-0752-4","article-title":"Role of 18FDG-PET\/CT in detecting relapse during follow-up of patients with Hodgkin\u2019s lymphoma","volume":"88","author":"Crocchiolo","year":"2009","journal-title":"Ann Hematol"},{"key":"10.1016\/j.crad.2010.03.012_bib6","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1200\/JCO.2008.16.1513","article-title":"Role of [18F]fluorodeoxyglucose positron emission tomography scan in the follow-up of lymphoma","volume":"27","author":"Zinzani","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.crad.2010.03.012_bib7","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.2967\/jnumed.109.065870","article-title":"The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies","volume":"50","author":"Lim","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2010.03.012_bib8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0074-7742(09)00407-3","article-title":"Application of pet imaging to diagnosis of Alzheimer\u2019s disease and mild cognitive impairment","volume":"84","author":"Noble","year":"2009","journal-title":"Int Rev Neurobiol."},{"key":"10.1016\/j.crad.2010.03.012_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2009.02.065","article-title":"Cardiac positron emission tomography","volume":"54","author":"Bengel","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.crad.2010.03.012_bib10","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1046\/j.1464-410x.1999.00349.x","article-title":"Positron emission tomography with 18fluorine-labelled deoxyglucose: utility in localized and advanced prostate cancer","volume":"84","author":"Sanz","year":"1999","journal-title":"BJU Int"},{"key":"10.1016\/j.crad.2010.03.012_bib11","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.2967\/jnumed.109.066639","article-title":"A comparison of 68Ga-DOTATATE and 18F-FDG PET\/CT in pulmonary neuroendocrine tumors","volume":"50","author":"Kayani","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2010.03.012_bib12","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.apradiso.2009.02.011","article-title":"Evaluation of patients with hepatocellular carcinomas using [ (11)C]acetate and [ (18)F]FDG PET\/CT: a preliminary study","volume":"67","author":"Hwang","year":"2009","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.crad.2010.03.012_bib13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.nic.2009.08.012","article-title":"Molecular imaging (PET) of brain tumors","volume":"19","author":"Basu","year":"2009","journal-title":"Neuroimaging Clin N Am."},{"issue":"4","key":"10.1016\/j.crad.2010.03.012_bib14","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/pbc.22363","article-title":"Pseudometastasis secondary to histoplasmosis infection: false-positive PET\/CT findings","volume":"54","author":"Perko","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.crad.2010.03.012_bib15","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1752-1947-3-124","article-title":"False positive diagnosis of malignancy in a case of cryptogenic organising pneumonia presenting as a pulmonary mass with mediastinal nodes detected on fluorodeoxyglucose-positron emission tomography: a case report","volume":"3","author":"Ponnuswamy","year":"2009","journal-title":"J Med Case Reports"},{"key":"10.1016\/j.crad.2010.03.012_bib16","first-page":"279","article-title":"Incidental inflammatory findings in nerves and in patients with neoplastic diseases evaluated by (18)F-FDG-PET\/CT","volume":"12","author":"Bertagna","year":"2009","journal-title":"Hell J Nucl Med"},{"key":"10.1016\/j.crad.2010.03.012_bib17","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.2967\/jnumed.108.054478","article-title":"The clinical value of myocardial blood flow measurement","volume":"50","author":"Camici","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2010.03.012_bib18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00345-004-0418-8","article-title":"PET and prostate cancer","volume":"22","author":"Sanz","year":"2004","journal-title":"World J Urol"},{"key":"10.1016\/j.crad.2010.03.012_bib19","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1097\/01.ju.0000056901.95996.43","article-title":"Value of [11C]choline positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography","volume":"169","author":"Picchio","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.crad.2010.03.012_bib20","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2214\/ajr.179.2.1790482","article-title":"Positive [11C]choline and negative [18F]FDG with positron emission tomography in recurrence of prostate cancer","volume":"179","author":"Picchio","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.crad.2010.03.012_bib21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0302-2838(03)00207-0","article-title":"11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer","volume":"44","author":"de Jong","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.crad.2010.03.012_bib22","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.2967\/jnumed.108.061507","article-title":"Influence of trigger PSA and PSA kinetics on 11C-choline PET\/CT detection rate in patients with biochemical relapse after radical prostatectomy","volume":"50","author":"Castellucci","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2010.03.012_bib23","first-page":"1642","article-title":"Detection and localization of prostate cancer: correlation of (11)C-choline PET\/CT with histopathologic step-section analysis","volume":"46","author":"Farsad","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2010.03.012_bib24","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1477-7819-5-68","article-title":"11C-choline vs. 18F-FDG PET\/CT in assessing bone involvement in patients with multiple myeloma","volume":"5","author":"Nanni","year":"2007","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.crad.2010.03.012_bib25","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/01.ju.0000142099.80156.85","article-title":"Prostate cancer localization with 18fluorine fluorocholine positron emission tomography","volume":"173","author":"Kwee","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.crad.2010.03.012_bib26","first-page":"262","article-title":"Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET","volume":"47","author":"Kwee","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2010.03.012_bib27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2310\/7290.2008.00002","article-title":"Use of step-section histopathology to evaluate 18F-fluorocholine PET sextant localization of prostate cancer","volume":"7","author":"Kwee","year":"2008","journal-title":"Mol Imaging"},{"key":"10.1016\/j.crad.2010.03.012_bib28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11307-005-0023-2","article-title":"Positron emission tomography\/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: meaningful at PSA <5 ng\/ml?","volume":"8","author":"Heinisch","year":"2006","journal-title":"Mol Imaging Biol."},{"key":"10.1016\/j.crad.2010.03.012_bib29","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00259-006-0150-2","article-title":"[18F]fluorocholine PET\/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients","volume":"33","author":"Cimitan","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2010.03.012_bib30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00259-007-0633-9","article-title":"PET\/CT imaging of recurrent prostate cancer","volume":"35","author":"Scher","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2010.03.012_bib31","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1148\/radiol.2352040494","article-title":"Fluorocholine PET\/CT in patients with prostate cancer: initial experience","volume":"235","author":"Schmid","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.crad.2010.03.012_bib32","first-page":"1249","article-title":"Imaging prostate cancer with 11C-choline PET\/CT","volume":"47","author":"Reske","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2010.03.012_bib33","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00259-006-0164-9","article-title":"PET\/CT in patients with hepatocellular carcinoma using [ (18)F]fluorocholine: preliminary comparison with [\u00a0(18)F]FDG PET\/CT","volume":"33","author":"Talbot","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2010.03.012_bib34","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3171\/jns.2006.104.2.238","article-title":"Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures","volume":"104","author":"Pirotte","year":"2006","journal-title":"J Neurosurg"},{"key":"10.1016\/j.crad.2010.03.012_bib35","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1080\/02688690701700935","article-title":"The role of advanced MR in understanding brain tumors pathology","volume":"21","author":"Price","year":"2007","journal-title":"Br J Neurosurg"},{"key":"10.1016\/j.crad.2010.03.012_bib36","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s00259-004-1598-6","article-title":"11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET","volume":"2","author":"Kim","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2010.03.012_bib37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00259-004-1564-3","article-title":"Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value","volume":"32","author":"Van Laere","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2010.03.012_bib38","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1212\/WNL.50.5.1316","article-title":"11C-methionine PET for differential diagnosis of low-grade gliomas","volume":"50","author":"Herholz","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.crad.2010.03.012_bib39","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3171\/jns.2001.95.5.0746","article-title":"Positron emission tomography with injection of methionine as a prognostic factor in glioma","volume":"95","author":"De Witte","year":"2001","journal-title":"J Neurosurg"},{"key":"10.1016\/j.crad.2010.03.012_bib40","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/1097-0142(20010915)92:6<1541::AID-CNCR1480>3.0.CO;2-D","article-title":"Positron emission tomography (11)C-methionine and survival in patients with low-grade gliomas","volume":"92","author":"Ribom","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.crad.2010.03.012_bib41","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00259-007-0531-1","article-title":"Adding 11C-methionine PET to the EORTC prognostic factors in grade 2 gliomas","volume":"35","author":"Smits","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2010.03.012_bib42","first-page":"778","article-title":"Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and\/or carbon-11-methionine","volume":"39","author":"Kaschten","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2010.03.012_bib43","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/jmri.20757","article-title":"Correlation between dynamic susceptibility contrast perfusion MRI and methionine metabolism in brain gliomas: preliminary results","volume":"24","author":"Sadeghi","year":"2006","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.crad.2010.03.012_bib44","first-page":"1293","article-title":"Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas","volume":"45","author":"Pirotte","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2010.03.012_bib45","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2004.02.013","article-title":"Role of 11-C-methionine positron emission tomography for the delineation of the tumor volume in pharyngo-laryngeal squamous cell carcinoma: comparison with FDG-PET and CT","volume":"71","author":"Geetsa","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.crad.2010.03.012_bib46","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00259-005-0008-z","article-title":"11C-methionine PET\/CT in 99mTc-sestamibi-negative hyperparathyroidism in patients with renal failure on chronic haemodialysis","volume":"33","author":"Rubello","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2010.03.012_bib47","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s00259-004-1610-1","article-title":"Pre-operative localisation of hyperfunctional parathyroid tissue with 11C-methionine PET","volume":"31","author":"Otto","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2010.03.012_bib48","first-page":"1766","article-title":"PET and parathyroid L-[carbon-11]methionine accumulation in hyperparathyroidism","volume":"37","author":"Sundin","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2010.03.012_bib49","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00006231-200502000-00009","article-title":"Localization of parathyroid adenomas using 11C-methionine positron emission tomography","volume":"26","author":"Beggs","year":"2005","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.crad.2010.03.012_bib50","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/cmmi.243","article-title":"Accurate pre-operative localization of pathological parathyroid glands using 11C-methionine PET\/CT","volume":"3","author":"Tang","year":"2008","journal-title":"Contrast Media Mol Imaging"},{"key":"10.1016\/j.crad.2010.03.012_bib51","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11307-009-0205-4","article-title":"Clinical value and limitations of [11C]-methionine PET for detection and localization of suspected parathyroid adenomas","volume":"11","author":"Herrmann","year":"2009","journal-title":"Mol Imaging Biol."},{"key":"10.1016\/j.crad.2010.03.012_bib52","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1148\/radiology.195.2.7724749","article-title":"Pancreatic neuroendocrine tumors: diagnosis with PET","volume":"195","author":"Ahlstrom","year":"1995","journal-title":"Radiology"},{"key":"10.1016\/j.crad.2010.03.012_bib53","first-page":"373","volume":"220","author":"Hoegerle","year":"2001","journal-title":"Whole-body 18F DOPA PET for detection of gastrointestinal carcinoid tumors. Radiology"},{"key":"10.1016\/j.crad.2010.03.012_bib54","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1148\/radiol.2222010622","article-title":"Pheochromocytomas: detection with 18F DOPA whole body PET\u2014initial results","volume":"222","author":"Hoegerle","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.crad.2010.03.012_bib55","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00259-003-1115-3","article-title":"18F-DOPA positron emission tomography for the detection of glomus tumours","volume":"30","author":"Hoegerle","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2010.03.012_bib56","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10689-004-2155-y","article-title":"Imaging of pheochromocytoma and paraganglioma","volume":"4","author":"Brink","year":"2005","journal-title":"Fam Cancer"},{"key":"10.1016\/j.crad.2010.03.012_bib57","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s002590000404","article-title":"18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels","volume":"28","author":"Hoegerle","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.crad.2010.03.012_bib58","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0969-8043(99)00057-3","article-title":"Fully automated synthesis module for the high yield one-pot preparation of 6- [18F]fluoro-L-DOPA","volume":"51","author":"de Vries","year":"1999","journal-title":"Appl Radiat Isotopes"},{"key":"10.1016\/j.crad.2010.03.012_bib59","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s00259-005-1904-y","article-title":"Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson\u2019s disease","volume":"33","author":"Eshuis","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2010.03.012_bib60","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1001\/archneur.1990.00530120034007","article-title":"The nigro-striatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson\u2019s Disease","volume":"47","author":"Leenders","year":"1990","journal-title":"Arch Neurol"},{"key":"10.1016\/j.crad.2010.03.012_bib61","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/jnnp.49.8.853","article-title":"Brain dopamine metabolism in patients with Parkinson\u2019s disease measured with positron emission tomography","volume":"49","author":"Leenders","year":"1986","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.crad.2010.03.012_bib62","first-page":"119","article-title":"Fluorine-18-FPCT: a PET radiotracer for imaging dopamine transporters","volume":"38","author":"Goodman","year":"1997","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2010.03.012_bib63","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0166-2236(90)90112-N","article-title":"Compensations after lesions of central dopaminergic neurons: some clinical and basic implications","volume":"13","author":"Zigmond","year":"1990","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.crad.2010.03.012_bib64","first-page":"62S","article-title":"Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs","volume":"46","author":"Kwekkeboom","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2010.03.012_bib65","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s00259-004-1697-4","article-title":"68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5","volume":"32","author":"Wild","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2010.03.012_bib66","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1007\/s00259-003-1255-5","article-title":"DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals","volume":"30","author":"Wild","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2010.03.012_bib67","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1158\/1078-0432.1136.11.3","article-title":"Preclinical evaluation of new and highly potent analogues of octreotide for predictive imaging and targeted radiotherapy","volume":"11","author":"Ginj","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.crad.2010.03.012_bib68","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00259-008-0769-2","article-title":"Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours","volume":"35","author":"Ambrosini","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2010.03.012_bib69","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s00259-006-0317-x","article-title":"Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?","volume":"34","author":"Antunes","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2010.03.012_bib70","first-page":"4","article-title":"PET imaging of prostate cancer with 11C-acetate","volume":"44","author":"Dimitrakopoulou-Strauss","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2010.03.012_bib71","first-page":"2","article-title":"11C-acetate: a new tracer for the evaluation of hepatocellular carcinoma","volume":"44","author":"Delbeke","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2010.03.012_bib72","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.2967\/jnumed.108.055087","article-title":"A prospective evaluation of 18F-FDG and 11C-acetate PET\/CT for detection of primary and metastatic hepatocellular carcinoma","volume":"49","author":"Park","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2010.03.012_bib73","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s00259-004-1687-6","article-title":"[18F]FLT-PET in oncology: current status and opportunities","volume":"31","author":"Been","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2010.03.012_bib74","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ymeth.2009.03.009","article-title":"Molecular imaging of proliferation in vivo: positron emission tomography with [18F]fluorothymidine","author":"Buck","year":"2009","journal-title":"Methods"},{"key":"10.1016\/j.crad.2010.03.012_bib75","doi-asserted-by":"crossref","first-page":"64S","DOI":"10.2967\/jnumed.107.046391","article-title":"Imaging of cell proliferation: status and prospects","volume":"49","author":"Bading","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2010.03.012_bib76","doi-asserted-by":"crossref","unstructured":"Vallabhajosula S. 18F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization. Semin Nucl Med; 37:400\u2013419.","DOI":"10.1053\/j.semnuclmed.2007.08.004"},{"key":"10.1016\/j.crad.2010.03.012_bib77","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11307-006-0039-2","article-title":"Positron emission tomography measurement of tumor metabolism and growth: its expanding role in oncology","volume":"8","author":"Shields","year":"2006","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.crad.2010.03.012_bib78","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.nucmedbio.2005.04.004","article-title":"True tracers: comparing FDG with glucose and FLT with thymidine","volume":"32","author":"Krohn","year":"2005","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.crad.2010.03.012_bib79","doi-asserted-by":"crossref","first-page":"96S","DOI":"10.1177\/009127001773744215","article-title":"Imaging cellular proliferation as a measure of response to therapy","volume":"41","author":"Krohn","year":"2001","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.crad.2010.03.012_bib80","first-page":"158","article-title":"New PET tracers for evaluation of solid tumors response to therapy","volume":"53","author":"Larson","year":"2009","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2010.03.012_bib81","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1007\/s00259-007-0401-x","article-title":"[18F]fluorocholine PET\/CT in the assessment of bone metastases in prostate cancer","volume":"34","author":"Beheshti","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2010.03.012_bib82","first-page":"183","article-title":"PET imaging of hypoxia","volume":"45","author":"Lewis","year":"2001","journal-title":"Q J Nucl Med"},{"key":"10.1016\/j.crad.2010.03.012_bib83","first-page":"1701","article-title":"Coronary flow and flow reserve by PET simplified for clinical applications using rubidium-82 or nitrogen-13-ammonia","volume":"37","author":"Yoshida","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2010.03.012_bib84","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF02940336","article-title":"Heterogeneity of regional nitrogen 13-labeled ammonia tracer distribution in the normal human heart: comparison with rubidium 82 and copper 62-labeled PTSM","volume":"1","author":"Beanlands","year":"1994","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.crad.2010.03.012_bib85","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1053\/j.semnuclmed.2004.09.006","article-title":"Cardiovascular molecular imaging","volume":"35","author":"Dobrucki","year":"2005","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.crad.2010.03.012_bib86","first-page":"477","article-title":"Assessment of myocardial blood flow using 15O-water and 1-11C-acetate in rats with small-animal PET","volume":"47","author":"Herrero","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2010.03.012_bib87","first-page":"2048","article-title":"PET of vascular endothelial growth factor receptor expression","volume":"47","author":"Cai","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2010.03.012_bib88","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1021\/mp060049x","article-title":"Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging","volume":"3","author":"Liu","year":"2006","journal-title":"Mol Pharm"},{"key":"10.1016\/j.crad.2010.03.012_bib89","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00259-006-0199-y","article-title":"PET imaging of apoptosis with 64Cu-labeled streptavidin following pretargeting of phosphatidylserine with biotinylated annexin-V","volume":"34","author":"Cauchon","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2010.03.012_bib90","first-page":"706","article-title":"Preclinical safety evaluation of 18F-FHBG: a PET reporter probe for imaging herpes simplex virus type 1 thymidine kinase (HSV1-tk) or mutant HSV1-sr39tk\u2019s expression","volume":"47","author":"Yaghoubi","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2010.03.012_bib91","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00259-004-1705-8","article-title":"O-(2- [ (18)F]fluoroethyl)-l-tyrosine PET in the clinical evaluation of primary brain tumours","volume":"32","author":"Weckesser","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2010.03.012_bib92","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s002590050370","article-title":"Evaluation of l-3- [123I]iodo-alpha-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy","volume":"26","author":"Bader","year":"1999","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.crad.2010.03.012_bib93","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s002590050541","article-title":"O-(2- [18F]fluoroethyl)- l-tyrosine and l-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study","volume":"27","author":"Weber","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.crad.2010.03.012_bib94","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2967\/jnumed.106.037895","article-title":"Prognostic value of O-(2-18F-fluoroethyl)- l-tyrosine PET and MRI in low-grade glioma","volume":"48","author":"Floeth","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2010.03.012_bib95","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11060-008-9526-4","article-title":"The positive predictive value of O-(2- [18F]fluoroethyl)- l-tyrosine (FET) PET in the diagnosis of a glioma recurrence after multimodal treatment","volume":"88","author":"Mehrkens","year":"2008","journal-title":"J Neurooncol"},{"key":"10.1016\/j.crad.2010.03.012_bib96","doi-asserted-by":"crossref","first-page":"730","DOI":"10.2967\/jnumed.107.050005","article-title":"Prognostic value of 18F-fluoroethyl- l-tyrosine PET and MRI in small nonspecific incidental brain lesions","volume":"49","author":"Floeth","year":"2008","journal-title":"J Nucl Med"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926010001790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926010001790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T16:22:35Z","timestamp":1757866955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926010001790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":96,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0009926010001790"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2010.03.012","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non FDG PET","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2010.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}